Delivery Order SPE2DB20D1109-SPE2DB25FP85L
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on September 26, 2025, for carvedilol ER 10 mg capsules (30-count) valued at $19,150.83. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 29, 2025. The delivery order supports pharmaceutical supply to federal medical procurement needs, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This award...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count units) with a ceiling value of $3,309.42 under firm fixed price terms. The order is scheduled for completion by September 19, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This is a non-set-aside competitive award issued as a child order under AmerisourceBergen's larger indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,537.02 to AmerisourceBergen Drug Corp for Carvedilol ER 20 mg capsules (30-count units) on June 16, 2025, with completion scheduled for June 17, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award based on capability demonstration. Performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count units) with a contract value of $4,488.88. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, reflecting open competition among...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Carvedilol ER 40 mg capsules (30-count units) with a contract value of $4,019.94 and a completion date of September 22, 2025. This is a firm fixed-price, non-competitive set-aside delivery order utilizing AmerisourceBergen's existing indefinite delivery contract vehicle with DLA Troop Support Medical. The order will be fulfilled at the contractor's facility in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count packaging) valued at $2,663.43, with completion targeted for September 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, a major...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on September 15, 2025, for Carvedilol ER 20 mg capsules (30-count packaging) with a ceiling value of $6,836.77. This is a firm fixed-price delivery order with an ultimate completion date of September 16, 2025, and no set-aside designation was used in the award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count) with a contract ceiling value of $2,339.36. This is a firm fixed-price delivery order with no set-aside designation, executed through open competition. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The contract has an ultimate completion date...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count packaging) valued at $1,110.73. This is a firm fixed-price delivery order with an ultimate completion date of September 23, 2025, and represents a non-competitive set-aside award. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a $1,736.21 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count units). This firm fixed price contract, which is not set-aside and was competitively awarded, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The order is scheduled for completion by September 4, 2025, with performance at AmerisourceBergen's...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP85LDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count units) under a firm fixed-price contract valued at $6,954.24. This is a non-set-aside competitive award with an ultimate completion date of September 30, 2025, with performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that supplies a broad portfolio of medications and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract awards demonstrate consistent capability to fulfill diverse pharmaceutical procurement requirements through competitive bidding, with delivery orders ranging from small transactions to substantial orders. This specific carvedilol supply order supports the company's ongoing role in the Defense Logistics Agency's medical supply chain and contributes to pharmaceutical availability for military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.0k | 9/29/25 |